MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, IRWD made $106,506K in revenue. $40,773K in net income. Net profit margin of 38.28%.

Income Overview

Revenue
$106,506K
Net Income
$40,773K
Net Profit Margin
38.28%
EPS
$0.24
Unit: Thousand (K) dollars
Revenue Breakdown
    • Collaborative Arrangements Linze...
    • Royalty
    • Abbvie Plc-Collaborative Arrange...
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
106,506 47,709 122,060 85,239
Research and development
21,940 21,863 22,468 23,373
Selling, general and administrative
12,033 19,293 21,908 16,795
Restructuring, net
-40 -252 2,200 -250
Total costs and expenses
33,933 40,904 46,576 39,918
Income (loss) from operations
72,573 6,805 75,484 45,321
Interest expense and other financing costs
9,141 7,886 8,434 8,356
Interest and investment income
1,698 1,459 930 818
Other
42 77 40 39
Other income (expense), net
-7,401 -6,350 -7,464 -7,499
Income (loss) before income taxes
65,172 455 68,020 37,822
Income tax expense
24,399 2,731 27,940 14,223
Net income (gain)
40,773 -2,276 40,080 23,599
Basic EPS
0.25 -0.014 0.25 0.15
Diluted EPS
0.24 -0.017 0.23 0.14
Basic Average Shares
163,451,000 162,456,000 162,215,000 161,723,000
Diluted Average Shares
166,690,000 136,357,000 177,764,000 176,837,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Collaborative ArrangementsLinzess$104,223K Royalty$887K AbbviePlc-Collaborative Arrangement...$105,110K (166.82%↑ Y/Y)AbbviePlc-Collaborative Arrangement...$808K (-0.37%↓ Y/Y)Astellas PharmaInc-Collaborative Arrangement...$347K (-6.97%↓ Y/Y)Asahi Kasei PharmaCorporation-Collaborative Arrangement...$162K (-66.04%↓ Y/Y)AstraZeneca-Collaborative Arrangement...$79K (-10.23%↓ Y/Y)Total revenues$106,506K (158.87%↑ Y/Y)Income (loss) fromoperations$72,573K (349.32%↑ Y/Y)Total costs andexpenses$33,933K (-51.70%↓ Y/Y)Restructuring, net-$40K (-100.22%↓ Y/Y)Income (loss) beforeincome taxes$65,172K (279.68%↑ Y/Y)Other income(expense), net-$7,401K (-3.31%↓ Y/Y)Interest and investmentincome$1,698K (95.40%↑ Y/Y)Other$42K (13.51%↑ Y/Y)Research and development$21,940K (-20.02%↓ Y/Y)Selling, general andadministrative$12,033K (-50.40%↓ Y/Y)Net income (gain)$40,773K (209.06%↑ Y/Y)Income tax expense$24,399K (2090.22%↑ Y/Y)Interest expense andother financing costs$9,141K (13.27%↑ Y/Y)

IRONWOOD PHARMACEUTICALS INC (IRWD)

IRONWOOD PHARMACEUTICALS INC (IRWD)